Neuropsychiatric implications of brain tryptophan perturbations appearing in hepatic encephalopathy

Advances in Experimental Medicine and Biology

Volumn 398, Issue , 1996, Pages 387-395

  Bengtsson, F ^a   Bergqvist, P ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; SEROTONIN; TRYPTOPHAN;

ANIMAL; BRAIN; HEPATIC ENCEPHALOPATHY; HUMAN; METABOLISM; OCCUPATIONAL DISEASE; PATHOLOGY; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT; REVIEW;

ANIMALS; BRAIN; HEPATIC ENCEPHALOPATHY; HUMANS; HYDROXYINDOLEACETIC ACID; OCCUPATIONAL DISEASES; SEROTONIN; TRYPTOPHAN;

EID: 0030346494     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4613-0381-7_60     Document Type: Article

References (71)

1. Agardh C-D., Carlsson A., Lindqvist M., Siesjö B.K., 1979, The effect of pronounced hypoglycemia on monoamine metabolism in rat brain. Diabetes 28:804.
2. Apelqvist G., Bergqvist P.B.F., Bugge M., and Bengtsson F., 1995, Autoradiographic characterization of regional brain 5-HT subreceptors changes in chronic experimental hepatic encephalopathy, submitted.
3. Badawy AA-B., Morgan C.J., Lane J., Dhaliwal K., Bradley D.M., 1989, Liver tryptophan pyrrolase. A major determinant of the lower brain 5-hydroxytryptamine concentration in alcohol-preferring C57BL mice. Biochem. J. 264:597.
4. Baldessarini R.J., Fischer J.E., 1973, Serotonin metabolism in rat brain after surgical diversion of the portal venous circulation. Nature New Biol. 245:25.
5. Basile A.S., Saito K., Al-Mardini H., Record C.O., Hughes R.D., Harrison P., Williams R., Li Y., and Heyes M.P., 1995a, The relationship between plasma and brain quinolinic acid levels and the severity of hepatic encephalopathy. Gastroenterology 108: 818.
6. Basile A.S., Saito K., Li Y., and Heyes M.P., 1995b, The relationship between plasma and brain quinolinic acid levels and the severity of hepatic encephalopathy in animal models of fulminant hepatic failure. J. Neurochem. 64: 2607.
7. Baumgarten H.G., Victor S.J., Lovenberg W., 1973, Effect of intraventricular injection of 5,7-dihydroxytriptamine on regional tryptophan hydroxylase of rat brain. J. Neurochem. 21:251.
8. Bengtsson F., 1991, Round table discussion on brain monoamines: some personal reflections. In: Bengtsson F, Jeppsson B., Almdal T., Vilstrup H., eds. Progress in hepatic encephalopathy and metabolic nitrogen exchange. Boca Raton, Florida, CRC Press Inc, pp. 233-239
9. Bengtsson F., Gage F.H., Jeppsson B., Nobin A., Rosengren E., 1985, Brain monoamine metabolism and behavior in portacaval-shunted rats. Exp. Neurol. 90:21.
10. Bengtsson F., Nobin A., Falck B., Gage F.H., Jeppsson B., 1986, Portacaval shunt in the rat: selective alterations in behavior and brain serotonin. Pharmacol. Biochem. Behav. 24:1611.
11. Bengtsson F., Bugge M., Vagianos C., Jeppsson B., Nobin A., 1987a, Brain serotonin metabolism and behavior in rats with carbon tetrachloride-induced liver cirrhosis. Res. Exp. Med. 187:429.
12. Bengtsson F., Bugge M., Hansson L., Fyge K., Jeppsson B., Nobin A., 1987b, Serotonin metabolism in the central nervous system following sepsis or portacaval shunt in the rat. J. Surg. Res. 43:420.
13. Bengtsson F., Nobin A., Falck B., Gage F.H., Jeppsson B., 1987c, Effect of oral branched chain amino acids on behavior and brain serotonin metabolism in portacaval shunted rats. World J. Surg. 12:246.
14. Bengtsson F., Ekman R., Nobin A.., 1987d, Substance P-like immunoreactivity in the rat central nervous system following portacaval shunt. Surg. Res. Comm. 2:65-69.
15. Bengtsson F., Bugge M., Brun A., Falck B., Henriksson K-G., Nobin A., 1988, The impact of time after portacaval shunt in the rat on behavior, brain serotonin, and brain and muscle histology. J. Neurol. Sci. 83:109.
16. Bengtsson F., Bugge M., Hall H., Nobin A., 1989a, Brain 5-HT1 and 5-HT2 binding sites following portacaval shunt in the rat. Res. Exp. Med. 189:249.
17. Bengtsson F., Bugge M., Nobin A., 1989b, Hepatocerebral dysfunction and brain serotonin. In: Butterworth R.F., Pomier Layrargues G., eds. Hepatic Encephalopathy. Humana Press, Clifton, New Jersey, pp. 355-387.
18. Bengtsson F., Boris-Möller F., Hansen A-J., Siesjö B.K., 1990, Extracellular pH in the rat brain during hypoglycemic coma and recovery. J. Cereb. Blood Flow Metab. 10:262.
19. Bengtsson F., Bugge M., Johansen K.H., Butterworth R.F., 1991, Brain tryptophan hydroxylation in the portacaval shunted rat: A hypothesis for the regulation of serotonin turnover in vivo. J. Neurochem. 56:1069.
20. Bergeron M., Reader T.A., Layrargues G.P., Butterworth R.F., 1989, Monoamines and metabolites in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. Neurochemical Research 14:853.
21. Bergeron M., Swain M.S., Reader T.A., Grondin L., Butterworth R.F., 1990, Effect of ammonia on brain serotonin metabolism in relation to function in the portacaval shunted rat. J Neurochem. 55:222.
22. Bergeron M.., Reader T.A., Butterworth R.F., 1991, Early changes of serotonin turnover in brain following portacaval anastomosis: Relation to altered sleep patterns and diurnal rhythms. In: Bengtsson F., Jeppsson B., Almdal T., Vilstrup H., eds. Progress I hepatic encephalopathy and metabolic nitrogen exchange. Boca Raton, Florida, CRC Press Inc, pp. 219-232.
23. Bergqvist P.B.F., Vogels B.A.P.M., Bosman D.K., Maas M.A.W., Hjorth S., Chamuleau R.A.F.M., and Bengtsson F., 1995a, Neocortical dialysate monoamines of rats after acute, subacute, and chronic liver shunt, J. Neurochem. 64: 1238.
24. Bergqvist P.B.F., Werner E.R., Apelqvist G., Bugge M., Wachter H., and Bengtsson F., 1995b, Brain biopterin metabolism in rats with chronic experimental hepatic encephalopathy. Metab. Brain Dis. 10: 143.
25. Bergqvist P.B.F., Heyes M.P., Bugge M., and Bengtsson F., 1995, Brain quinolinic acid in chronic experimental hepatic encephalopathy: effects og an exogenous ammonium acetate challenge, J. Neurochem. 65: in press.
26. Bergqvist P.B.F., Heyes M.P., Apelqvist G., Butterwoth R.F., and Bengtsson F., 1995, Brain extracellular quinolinic acid in chronic experimental hepatic encephalopathy as assessed by in vivo microdialysis: effects of pharmacological manipulation of the L-tryptophan availability, submitted.
27. Bloxam D.L., Curzon G., 1978, A study of proposed determinants of brain tryptophan concentrations in rats after portocaval anastomosis or sham operation. J Neurochem 31:1255.
28. Bugge M., Bengtsson F., Nobin A., Jeppsson B., Herlin P., 1986, Metabolism of monoamines in the brain after total hepatectomy in the rat. Exp. Neurol. 94:11.
29. Bugge M., Bengtsson F., Nobin A., Jeppsson B., Herlin P., 1987a, The turnover of brain monoamines after total hepatectomy in rats infused with branched chain amino acids. World J. Surg. 11:810.
30. Bugge M., Bengtsson F., Nobin A., Jeppsson B., Herlin P., 1987b, The effect of liver ischaemia on brain monoamine synthesis in the rat. Res. Exp. Med. 187:119-130.
31. Bugge M., Bengtsson F., Nobin A., Jeppsson B., Hultberg B., Jonung T., Herlin P., 1988, Serotonin metabolism in the rat brain following ammonia administration. In: Soeters P.B., Wilson J.M.P., Meijer A.J., Holm E., eds. Advances in ammonia metabolism and hepatic encephalopathy. Amsterdam, Exerpta Medica, International Congress Series 761, Elsevier Science Publishers B.B., pp 454-461.
32. Bugge M., Bengtsson F., Nobin A., Hall H., Wedel I., Jeppsson B., Herlin P., 1989, Serotonin receptors in the brain following total hepatectomy in rats treated with branched-chain amino acids. J. Parenter. Enterai Nutr. 13:235-239.
33. Butterworth R.F., 1992, Pathogenesis and treatment of portal-systemic encephalopathy: an update. Dig Dis Sci 37:321.
34. Calderini G., Carlsson A., Nordström C-H., 1978, Monoamine metabolism during bicuculline-induced epileptic seizures in the rat. Brain Res. 157:295.
35. Carboni E., Cadoni C., Tanda G.L., Di Chiara G., 1989, Calcium-dependent, tetrodotoxin-sensitive stimulation of cortical serotonin release after a tryptophan load. J. Neurochem. 53:976.
36. Carlsson A., Lindqvist M., 1973, In vivo measurements of tryptophan and tyrosine hydroxylase activities in mouse brain. J. Neural. Transm. 34:79.
37. Conn HO, Liebertahl M.M., 1979, The hepatic coma syndromes and lactulose. The Williams & Wilkins Co, Baltimore,
38. Cummings M.G., James J.H., Soeters P.B., Keane J.M., Foster J., Fischer J.E., 1976a, Regional brain study of indoleamine metabolism in the rat in acute hepatic failure. J.Neurochem. 27:741.
39. Cummings M.G., Soeters P.B., James J.H., Keane J.M., Fischer J.E., 1976b, Regional brain indoleamine metabolism following chronic portacaval anastomosis in the rat. J Neurochem 27:501.
40. Curzon G., Kantamaneni B.D., Winch J., Rojas-Bueno A., Murray-Lyon I.M., Williams R., 1973, Plasma and brain tryptophan changes in experimental acute hepatic failure. J Neurochem 21:137.
41. Curzon G., Kantamaneni B.D., Fernando J.C., Woods M.S., Cavanagh J.B., 1975, Effects of chronic portocaval anastomosis on brain tryptophan, tyrosine and 5-hydroxy-tryptamine. J Neurochem 24:1065
42. Denis J., Delorme M.L., Boschat M., Nordlinger B., Opolon P., 1983, Respective roles of ammonia, amino acids, and medium-sized molecules in the pathogenesis of experimentally induced acute hepatic encephalopathy. J. Neurochem. 40:10.
43. Erecinska M., Patuszko A., Wilson D.F., Nelson D., 1987, Ammonia-induced release of neurotransmitters from rat brain synaptosomes: differences between the effects of amines and amino acids. J. Neurochem. 49:1258.
44. Grahame-Smith D.G. 1973, Does the total turnover of brain 5-HT reflect the functional activity of 5-HT in brain? In: Barchas J., Usdin E., eds. Serotonin and behavior. New York, London, Academic Press, pp 5-7.
45. Herlin P.M., James J.H., Gimmon Z., Fischer J.E., 1982, Combined or individual administration of branched-chain amino acids following total hepatectomy in the rat: effects on amino acids and indoleamines in brain. J Parenter. Enter. Nutr. 6:383.
46. Holmin T., Siesjö B.K. 1974, The effect of porta-caval anastomosis upon the energy state and upon acid-base parameters of the rat brain. J. Neurochem. 22:403.
47. Jellinger K., Riederer P., 1977, Brain monoamines in metabolic (endotoxic) coma. A preliminary biochemical study in human postmortem material. J Neural. Transm. 41:275.
48. Johansson O., Hökfelt T., Pernow B., Jeffcoate S.L., White N., Steinbusch H.W.M., Berhofstad A.A.J., Emsson P.C., Spindel E., 1981, Immunohistochemical support for three putative transmitters in one neuron: Coexistence of 5-hydroxytryptamine, substance P and thyrotropin releasing hormone-like immunoreactivity in medullary neurons projecting to the spinal cord. Neuroscience 6:1857
49. Jonung T., Ramzy A., Herlin P., James J.H., Edwards L., Fischer J.E., 1985, Indole amines and amino acids in various brain regions after infusion of branched chain amino acids into hepatectomized rats. Eur. Surg. Res. 17:83.
50. Kamata S., Okada A., Watanabe T., Kawashima Y., Wada H., 1980, Effects of dietary amino acids on brain amino acids and transmitter amines in rats with a portacaval shunt. J.Neurochem. 35:1190
51. Knott P.J., Curzon G., 1974, Effects of increased rat brain tryptophan on 5-hydroxytryptamine and 5-hydroxy-indoleacetic acid in the hypothalamus and other brain regionons. J Neurochem 22:1065.
52. Lookingland K.J., Shannon N.J., Chapin D.S. Moore K.E., 1986, Exogenous tryptophan increases synthesis, storage, and intraneuronal metabolism of 5-hydroxytryptamine in the rat hypothalamus. J. Neurochem. 47:205.
53. Martin J.R., Dedek J., Driscoll P., 1983. Portacaval anastomosis in rats: effects on behaviour and brain serotonin metabolism. Pharmacol. Biochem. Behav. 18:269.
54. Mans A.M., Hawkins R.A., 1986, Brain monoamines after portacaval anastomosis. Metabolic Brain Disease 1:45.
55. Mans A.M., DeJoseph M.R., Davis D.W., Vina J.R., Hawkins R.A., 1990, Early establishment of cerebral dysfunction after portacaval shunting. Am. J. Physiol. 259:E104.
56. Moroni F., Carlà V., Lombardi G., Pellegrini D., Carassale G.L., Cortesini F., 1984, Excitatory amino acids, tryptophan metabolites, and endogenous neurotoxins in porta-caval shunted rats. In: Kleinberger G., Ferenci P., Riederer P., Thaler H., eds. Advances in hepatic encephalopathy and urea cycle diseases. Basel, Karger, pp 385-393.
57. Moroni F., Lombardi G., Carlà V., Pellegrini D., Carassale G.L., Cortesini C., 1986a, Content of quinolinic acid and of other tryptophan metabolites increases in brain regions of rats used as experimental models of hepatic encephalopathy. J. Neurochem. 46:869.
58. Moroni F., Lombardi G., Carlà V., Lal S., Etienne P., Nair N.P.V., 1986b, Increase in the content of quinolinic acid in cerbrospinal fluid and frontal cortex of patients with hepatic failure. J. Neurochem. 47:1667.
59. Mousseau D.D., 1993, Tryptamine: a metabolite of tryptophan implicated in various neuropsychiatrie disorders. Metab. Brain Dis., 8: 1.
60. Ono J, Huston D.G., Dombro R.S., Levi J.U., Livingstone A., Zeppa R., 1978, Tryptophan and hepatic coma. Gastroenterology 74:196.
61. Peroutka S.J., 1990, Receptor "families" for 5-hydroxytryptamine. J. Cardiovasc. Pharmacol. 16(suppl 3):S8.
62. Reichle R.M., Reichle F.A., 1975, Effect of portacaval shunt and acute hepatic ischemia on brain and liver serotonin and catecholamines. Surg. Forum 26:413.
63. Robinson M.B., Anegawa N.J., Gorry E., Qureshi I.A., Coyle J.T., Lucki I., Batshaw M.L., 1992, Brain serotonin2 and serotonin1A receptors are altered in the congenitally hyperammonemic sparse fur mouse. J. Neurochem. 58:1016.
64. Sherlock S., Summerskill W.H.J., White L.P., Phear E.A., 1954, Portal-systemic encephalopathy. Neurological complications of liver disease. Lancet 11:453.
65. Siesjö B.K., Bengtsson F., 1989, Calcium fluxes, calcium antagonists, and calcium-related pathology in brain ischemia, hypoglycemia and spreading depression: a unifying hypothesis. J. Cereb. Blood. Flow Metab. 9:127.
66. de Simoni G.M., Sokola A., Fodritto F., Dal Toso G., Algeri S., 1987, Functional meaning of tryptophan-induced increase of 5-HT metabolism as clarified by in vivo voltammetry. Brain Research 411:89.
67. Tyce G.M., Flock E.V., Owen C.A., Stobie G.H.C., David C., 1967, 5-Hydroxyindole metabolism in the rat brain after hepatectomy. Biochem. Pharmol. 16:979.
68. Tricklebank M.D., Smart J.L., Bloxam D.L., Curzon G., 1978, Effects of chronic experimental liver dysfunction and L-tryptophan on behaviour in the rat. Pharmacol. Biochem. Behav. 9:181.
69. Tricklebank M.D., Bloxam D.L., Kantamaneni B.D., Curzon G., 1981, Brain 5-hydroxytryptamine metabolism after portacaval anastomosis: Relationship with ambulation. Pharmacol. Biochem. Behav. 14:259.
70. Woodward J.J., Blair R., 1991, Redox modulation of N-Methyl-D-Aspartate-stimulated neurotransmitter release from rat brain slices. J. Neurochem. 57:2059.
71. Wolf W.A., Ziaja E., Arthur Jr R.A., Anastasiadis Z, Levine R.A., Kuhn D.M., 1991, Effect of tetrahydrobiopterin on serotonin synthesis, releas and metabolism in superfused hippocampal slices. J. Neurochem. 57:1191.